# LLM call: summary

- Turn: 4
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 807
- Completion tokens: 389
- Total tokens: 1309
- Cost (USD): 0.00016

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1694: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Routine port audit had exposed long-dwelling intrusions in operators across two EU states and three continents; Commission funded sensors, segmented backups and exercises with 50% cost-sharing, but staffing lagged. Autonomous capabilities had outpaced evaluation; Washington pressed The Hague to expand servicing controls and Council built coercion file with Tokyo/Seoul. Permitting accelerated but grid lagged.

In H1 2027 frontier funding withdrew, cancelling private half of gigafactory plans; Brussels re-scoped first two sites to public anchor financing, holding grid reservations. Washington extended servicing demands to older tools; Commission tabled coercion file, tied licences to reciprocity, sent joint team to Tokyo/Seoul on shared servicing and pooled mature-node capacity, issued blocking clarification. Leaked tests showed emergent capabilities and observation-dependent agents; control/interpretability certification spread to labs, procurement, grid rollout.

By late 2027 machine-speed patching and behavioural detection were adopted and October exercise ran near full strength after cost-sharing tied to standard, catching intrusions earlier. Insurers moved to exclude/reprice model-enabled cyber losses, leaving hospitals/ports/telecoms exposed; Commission proposed EU Critical-Sector Cyber Insurance Backstop for hardened operators only, still under negotiation with no cover available. One capital signed separate hyperscaler hosting/supply deal undercutting common reciprocity line; Commission chose quiet containment. Taiwan manoeuvres again raised shipping insurance and chip costs; gigafactories remained on public money without private investors.

CURRENT NARRATIVE:
### The lab warning and the clinic promise
The first half of 2028 delivered two opposite stories about biology. A contested genome-model paper claimed a non-expert with assistance could reach a viable human-infecting design. Virologists argued over methods and over publication itself, but health-security officials treated it as different from past alarms. At the same time, tailored therapies for previously untreatable conditions reached ordinary clinics, with waiting lists filling within weeks.

Brussels tried to hold both stories. Health ministers tasked the EU health emergency body and disease-control agency to bulk-buy sequencers, link hospital syndromic reporting and enforce screening by synthesis providers, while funding a rapid verification effort with vetted access to the disputed study.

Progress was partial. Procurement moved, two hospital networks linked feeds, but screening enforcement stalled over inspection powers and verification results remained inconclusive by June. Laboratories kept the contested methods behind closed doors; hospitals did not yet see detection they could use.

### Hardening without cover
The push to finish hardening of energy, health and telecoms became the binding priority. The EU cybersecurity agency moved to make machine-speed patching and behavioural detection formal requirements, and energy funding was tied to staffing joint security centres.

Operators did staff up and adoption widened, yet renewals loomed uncovered. Finance ministers still had not agreed the guarantee behind the proposed reinsurance pool for critical sectors, leaving hardened hospitals and ports facing exclusions they could not pay to remove. A few curtailed non-urgent services to self-insure.

Cohesion frayed further. The capital with its separate hyperscaler deal kept its arrangement despite offtake offers, and talks in Tokyo and Seoul on servicing and older-node capacity produced minutes more than machines. Chip and shipping costs stayed high after renewed manoeuvres around Taiwan, and the two publicly financed factory sites stayed without private co-investors.

By June, clinics could promise cures Brussels could not supply on its own terms, while defenders and doctors alike waited for cover that had not arrived.
```

## Raw response

```
Routine audits had exposed long intrusions; EU funded sensors, backups, exercises with cost-sharing, adopted machine-speed patching and behavioural detection, but staffing lagged and insurers excluded model-enabled cyber losses. Commission's Critical-Sector reinsurance backstop remained unagreed with no cover. Autonomous capabilities outpaced evaluation; Washington expanded servicing controls, EU tabled coercion file, reciprocity licences, blocking clarification, and joint work with Tokyo/Seoul yielded little. One capital kept separate hyperscaler deal. Permitting accelerated but grid lagged; frontier funding withdrawal left two gigafactories on public anchor financing without private investors; Taiwan manoeuvres kept chip/shipping costs high.

In H1 2028 a contested genome-model paper claimed AI-assisted non-expert viable human-pathogen design; Brussels tasked HERA/ECDC to bulk-buy sequencers, link syndromic reporting and enforce synthesis screening while funding rapid verification. Procurement moved and two hospital networks linked, but screening stalled on inspection powers and verification was inconclusive. Tailored therapies reached clinics with long waiting lists. Hardening of energy/health/telecoms became binding priority with formal requirements and funding tied to joint security-centre staffing; adoption widened but renewals remained uncovered, forcing service curtailments to self-insure.
```
